Association and interaction of PPARα, δ, and γ gene polymorphisms with low-density lipoprotein-cholesterol in a Chinese Han population.

Appropriate LDL-C-to-HDL-C Ratio Cutoffs for Categorization of Cardiovascular Disease Risk Factors among Uygur Adults in Xinjiang, China. Int J Environ Res Public Health (2016) 0.77

Interaction between peroxisome proliferator-activated receptor gamma polymorphism and obesity on type 2 diabetes in a Chinese Han population. Diabetol Metab Syndr (2017) 0.75

Distinct but complementary contributions of PPAR isotypes to energy homeostasis. J Clin Invest (2017) 0.75

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA (2001) 118.65

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature (1990) 11.92

PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell (1998) 7.91

2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol (2013) 5.97

SNPStats: a web tool for the analysis of association studies. Bioinformatics (2006) 5.84

A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence. Am J Hum Genet (2007) 4.46

Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation (1998) 4.39

Mathematical multi-locus approaches to localizing complex human trait genes. Nat Rev Genet (2003) 4.18

[Chinese guidelines on prevention and treatment of dyslipidemia in adults]. Zhonghua Xin Xue Guan Bing Za Zhi (2007) 3.82

The language of gene interaction. Genetics (1998) 2.98

ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis (2011) 2.90

LDL Particle Number and Risk of Future Cardiovascular Disease in the Framingham Offspring Study - Implications for LDL Management. J Clin Lipidol (2007) 2.21

Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications--a review. Nutr J (2014) 1.82

Origins and evolution of spliceosomal introns. Annu Rev Genet (2006) 1.62

Activation of peroxisome proliferator-activated receptor (PPAR)delta promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese men. Diabetes (2007) 1.52

PPARgamma regulates adipocyte cholesterol metabolism via oxidized LDL receptor 1. J Clin Invest (2005) 1.49

Genetic linkage studies. Lancet (2005) 1.47

The function of introns. Front Genet (2012) 1.42

Foam cells in atherosclerosis. Clin Chim Acta (2013) 1.39

Dietary and genetic probes of atherogenic dyslipidemia. Arterioscler Thromb Vasc Biol (2005) 1.25

Mapping quantitative trait loci for complex binary traits in outbred populations. Heredity (Edinb) (1999) 1.19

LDL-cholesterol versus HDL-cholesterol in the atherosclerotic plaque: inflammatory resolution versus thrombotic chaos. Ann N Y Acad Sci (2012) 1.19

Exploring genetic determinants of plasma total cholesterol levels and their predictive value in a longitudinal study. Atherosclerosis (2010) 1.09

Peroxisome proliferator-activated receptors, metabolic syndrome and cardiovascular disease. Future Cardiol (2010) 1.06

Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention? Cardiovasc Diabetol (2012) 0.98

Enhancing the efficiency of transgene expression. Philos Trans R Soc Lond B Biol Sci (1993) 0.96

Effects of aleglitazar, a balanced dual peroxisome proliferator-activated receptor α/γ agonist on glycemic and lipid parameters in a primate model of the metabolic syndrome. Cardiovasc Diabetol (2011) 0.91

Peroxisome proliferator-activated receptor delta +294T > C polymorphism and serum lipid levels in the Guangxi Bai Ku Yao and Han populations. Lipids Health Dis (2010) 0.89

Lipid effects of peroxisome proliferator-activated receptor-δ agonist GW501516 in subjects with low high-density lipoprotein cholesterol: characteristics of metabolic syndrome. Arterioscler Thromb Vasc Biol (2012) 0.89

Peroxisome proliferator-activated receptor alpha polymorphisms and postprandial lipemia in healthy men. J Lipid Res (2007) 0.86

Gene-diet interactions on plasma lipid levels in the Inuit population. Br J Nutr (2012) 0.85

[Study on the prevalence of metabolic syndrome among 35-74 year-olds in Jiangsu province]. Zhonghua Liu Xing Bing Xue Za Zhi (2006) 0.82

PPARα polymorphisms as risk factors for dyslipidemia in a Brazilian population. Mol Genet Metab (2010) 0.81

PPAR α and PPAR γ polymorphisms as risk factors for dyslipidemia in a Chinese Han population. Lipids Health Dis (2014) 0.81

Interaction of PPARG Pro12Ala with dietary fat influences plasma lipids in subjects at cardiometabolic risk. J Lipid Res (2011) 0.81

Genotypes associated with lipid metabolism contribute to differences in serum lipid profile of GH-deficient adults before and after GH replacement therapy. Eur J Endocrinol (2012) 0.77